Early onset of effect of treatment with cladribine tablets for relapsing-remitting multiple sclerosis in the 96-week, phase III, double-blind, placebo-controlled CLARITY study
暂无分享,去创建一个
P. Vermersch | S. Greenberg | G. Comi | G. Giovannoni | P. Chang | P. Rieckmann | S. Cook | K. Rammohan | B. Musch | A. Hamlett | P. Sørensen | R. Verjee